Hernandez-GarciaA., KraftD.J., JanssenA.F.J., et al. (2014). Design and self-assembly of simple coat proteins for artificial viruses. Nat. Nanotechnol., 9, 698–702.
2.
HolkersM., MaggioI., HenriquesS.F.D., et al. (2014). Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat. Methods [Epub ahead of print]; DOI: 10.1038/nmeth.3075. Available at www.nature.com/nmeth/journal/vaop/ncurrent/full/nmeth.3075.html (accessed Sept.4, 2014).
3.
KiritsiD., GarciaM., BranderR., et al. (2014). Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa. J. Invest. Dermatol., 134, 2097–2104.
4.
LinnemannC., HeemskerkB., KvistborgP., et al. (2013). High-throughput identification of antigen-specific TCRs by TCR gene capture. Nat. Med., 19, 1534–1541.
5.
Prosensa (2014) Prosensa announces 2nd quarter 2014 financial results and recent corporate developments. Available at http://ir.prosensa.eu/releasedetail.cfm?ReleaseID=865701 (accessed Sept.3, 2014).
6.
uniQure and InoCard (2014). uniQure acquires cardiology gene therapy company InoCard. Available at www.uniqure.com/news/205/182/uniQure-Acquires-Cardiology-Gene-Therapy-Company-InoCard.html (accessed Sept.3, 2014).
7.
van LoenenM.M., de BoerR., van LiemptE., et al. (2014). A Good Manufacturing Practice procedure to engineer donor virus-specific T-cells into potent anti-leukemic effector cells. Haematologica, 99, 759–768.
